fluoxetine has been researched along with taurochenodeoxycholic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cai, W; Khaoustov, VI; Le, W; Pan, T; Xie, Q; Yoffe, B | 1 |
| Gao, MH; Gong, Y; Hu, WF; Huang, C; Lu, X; Wang, P; Wu, Y; Yang, RR; Zhang, JL | 1 |
| Chen, Z; Cheng, L; Huang, C | 1 |
4 other study(ies) available for fluoxetine and taurochenodeoxycholic acid
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiviral Agents; Cell Cycle; Depressive Disorder, Major; Desipramine; Down-Regulation; Fluoxetine; Gene Expression; Hepatoblastoma; Humans; Interferon-alpha; Jurkat Cells; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Receptor, Serotonin, 5-HT1A; Receptors, Glucocorticoid; Taurochenodeoxycholic Acid | 2005 |
Tauroursodeoxycholic acid produces antidepressant-like effects in a chronic unpredictable stress model of depression via attenuation of neuroinflammation, oxido-nitrosative stress, and endoplasmic reticulum stress.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Endoplasmic Reticulum Stress; Fluoxetine; Hindlimb Suspension; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitrosative Stress; Oxidative Stress; Prefrontal Cortex; Stress, Psychological; Swimming; Taurochenodeoxycholic Acid | 2018 |
Tauroursodeoxycholic Acid Ameliorates Lipopolysaccharide-Induced Depression Like Behavior in Mice via the Inhibition of Neuroinflammation and Oxido-Nitrosative Stress.
Topics: Animals; Antidepressive Agents; Cytokines; Depression; Disease Models, Animal; Fluoxetine; Hippocampus; Inflammation; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nitrosative Stress; Oxidative Stress; Prefrontal Cortex; Taurochenodeoxycholic Acid; Tumor Necrosis Factor-alpha | 2019 |